Ganciclovir 250 mg Oral Capsule
RxNorm 314007
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 314007 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ganciclovir 250 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Ganciclovir 250 mg Oral Capsule
(Atom ID: 12339921)
PSN
Prescribable Name (PSN):
Ganciclovir 250 mg Oral Capsule
(Atom ID: 6369355)
PT
Designated preferred name (PT):
Ganciclovir 250 mg oral capsule
(Atom ID: 10299108)
FN
Full form of descriptor (FN):
Product containing precisely ganciclovir 250 mg/1 each conventional release oral capsule (clinical drug)
(Atom ID: 10312953)
Patient Education
Ganciclovir
Ganciclovir capsules are used to treat cytomegalovirus (CMV) retinitis (eye infection that can cause blindness) in people whose immune system is not working normally. Ganciclovir capsules are used to treat CMV retinitis after the condition has been controlled by intravenous (injected into a vein) ganciclovir. Ganciclovir is also used to prevent cytomegalovirus (CMV) disease in people who have acquired immunodeficiency syndrome (AIDS) or who have received an organ transplant and are at risk of CMV disease. Ganciclovir is in a class of medications called antivirals. It works by preventing the spread of CMV disease or slowing the growth of CMV.
[Learn More]
* Please review the disclaimer below.